We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr Jay Naik at Spire include:
I am a Consultant Medical Oncologist specialising in cancer diagnosis, medical treatment, and follow-up for women and men with breast cancer, with an emphasis in helping patients to understand their disease and rationale for treatment. I have expertise in treating patients with newly diagnosed early breast cancer, either before or after surgery, and in those people where cancer returns sometime after previous treatments.
I studied medicine at Leeds University, qualifying in 1998. I trained in general medicine in Scarborough, Hull and Leeds, and then completed my oncology training in Leeds and associated peripheral hospitals in West Yorkshire. I undertook research training as a Cancer Research UK funded Fellow, also in Leeds. I completed my PhD in 2009, studying the use of viruses to stimulate the immune system against cancer. I became a consultant in 2011, initially working in Wakefield and Dewsbury (Mid Yorkshire NHS Trust), before moving to Harrogate early in 2020.
Modern treatment for cancer requires the careful integration of diagnostic procedures, surgical treatment, medical therapies with chemotherapy, biological or endocrine therapy, and radiotherapy. I therefore work as part of a multidisciplinary team including pathologists, radiologists, oncologists, surgeons, and specialist nurses who meet on a regular basis to consider the diagnosis and best treatment for each patient.
Increasingly therapies exploit knowledge of the nature of each individual tumour. Treatments have advanced remarkably in recent years by identifying specific changes present in cancer cells for which targeted drugs are available. More specific choices for treatment consequently may be found, with better chances of success. As such I am familiar in the analysis of the individual tumour of patients, with several standard tests applied to refine treatment choices for breast cancers and, where appropriate, special tests to guide treatment using technologies.
I now have several years of experience treating breast cancer in men as well as in women, using treatments including chemotherapy, hormone therapies, as well as new biological and molecular targeted treatments.
I have held regional Leadership roles, chairing the 'Yorkshire Cancer Network' Breast multidisciplinary group for three years during which time I placed an emphasis on education and audit with the aim of improving the day to day care delivered for patients in West Yorkshire.
I believe in the value of clinical research, and aside from my PhD, I have been involved as a primary investigator on several breast cancer trials in Mid Yorkshire, including: Add Aspirin; Persephone; EPHOS-B; ESTHER and Bridging the Age Gap. I recognise that gaps in overall knowledge remain, and the importance of trying to answer questions that will continue to improve care going into the future. I have been involved in the publication of several projects and academic papers highlighting some of these advances.
|Telephone||Insured patients 0113 218 5908/9, self-pay patients 0113 218 5967|
21 March 2020
Spire Healthcare has announced that it has dedicated its hospitals and resources to the NHS to support the fight against…
04 March 2020
Ovarian Cancer Awareness Month runs throughout March.